Chemical Structure (Lofexidine Tablets 1)
Lofexidine Hydrochloride Tablet, Film Coated
Product Images NDC 66993-345
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lofexidine Hydrochloride (NDC 66993-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Lofexidine Tablets 2)
Figure 2 (Lofexidine Tablets 3)
This text provides information on the mean SOWS-Gossop scores for different treatments (Lofexidine 2.16mg, Lofexidine 2.88mg, and Placebo) with corresponding 95% confidence intervals. This data appears to be related to a study conducted on a specific study day.*
Figure 3 (Lofexidine Tablets 4)
Figure 4 (Lofexidine Tablets 5)
36 Ct (Lofexidine Tablets 6)
This is not readable.*
96 Count (Lofexidine Tablets 7)
This text appears to be information related to Lofexidine Tablets in 0.18 mg dosage. These tablets must be stored and dispensed in their original container, protected from heat and moisture. The package contains prescribing information and storage conditions including keeping the tablets at 25°C with excursions permitted between 15°C to 30°C. The text also describes the active ingredient Lofexidine as well as the need to keep the tablets away from heat and moisture. Additionally, it mentions Not removing desiccants and keeping the bottle tightly closed.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
